Study record

MOTS-c interacts synergistically with exercise intervention to regulate PGC-1α expression, attenuate insulin resistance and enhance glucose metabolism in mice via AMPK signaling pathway

Yang B, Yu Q, Chang B et al. · Biochim Biophys Acta Mol Basis Dis · 2021

AnimalSeveralEvidence tier CAlso: Cell study (in vitro)

What this study reported

Reported lower skeletal muscle and plasma MOTS-c in high-fat-diet obese mice, and higher MOTS-c, PGC-1α and GLUT4 levels together with increased AMPK and ACC phosphorylation after treadmill training. In C2C12 myotubes, AMPK inhibition or PGC-1α knockdown lowered MOTS-c expression, while PGC-1α overexpression or added recombinant MOTS-c raised it.

Limitations

Male mice of a single strain, no blinding described, and mechanistic conclusions rest on one myotube line with pharmacological inhibitors; the design cannot separate MOTS-c effects from general training adaptations.

Study record

Annotated fields for this study
Study modelAnimal study (in vivo)
Substance studiedSeveralMore than one of these is central to the paper (common for reviews).
Speciesmouse
System studiedHigh-fat-diet obese C57BL/6 mice with treadmill training, and C2C12 myotubes with AMPK inhibition or PGC-1α manipulation
PopulationNot reported
DesignControlled animal experiment with cell culture experiments
Sample size as reportedNot reported
Control groupsedentary high-fat-diet mice and untreated myotubes
Route (data field only)Not reported
Endpoints measuredmuscle and plasma MOTS-c; PGC-1α expression; GLUT4 expression; AMPK and ACC phosphorylation; glucose metabolism
Pathways measuredAMPK signalling · SIRT1 / PGC-1α / biogenesis · Insulin & glucose handling · Folate cycle / purines / AICAR
Research areasMetabolic · Exercise · Skeletal muscle
Evidence tierC — Animal in vivo
Publication typesJournal Article, Research Support, Non-U.S. Gov't

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Direct
Model applicability
Mammalian
Sample size
Not reported
Controls
Appropriate
Outcome validity
Surrogate
Support for its own conclusion
Moderate

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.